Click on image to view larger version.

Figure 2 Kaplan-Meier Curves and Survival Table for the End Point of TVR to 1,080 Days

In patients treated with the Cypher stent (Cordis), freedom from target vessel revascularization (TVR) remains significantly better than vascular brachytherapy throughout the 3-year follow-up period (log-rank p = 0.022).